☆ 4.5 Article

Prognosis and Personalized Treatment Prediction in Different Mutation-Signature Hepatocellular Carcinoma

JOURNAL OF HEPATOCELLULAR CARCINOMA (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Biotechnology & Applied Microbiology

Long noncoding RNA LINC01234 promotes hepatocellular carcinoma progression through orchestrating aspartate metabolic reprogramming

Muhua Chen et al.

Summary: In hepatocellular carcinoma, the long noncoding RNA LINC01234 promotes cell proliferation, migration, and drug resistance by orchestrating aspartate metabolic reprogramming. LINC01234 downregulates the expression of argininosuccinate synthase 1 (ASS1), leading to activation of the mammalian target of rapamycin pathway and promoting HCC progression.

MOLECULAR THERAPY (2022)

添加到收藏夹

Article Immunology

Stemness Refines the Classification of Colorectal Cancer With Stratified Prognosis, Multi-Omics Landscape, Potential Mechanisms, and Treatment Options

Zaoqu Liu et al.

Summary: This study deciphers two stemness clusters in colorectal cancer (CRC), which have stratified prognosis, multi-omics landscape, potential mechanisms, and treatment options. It provides new insights into the heterogeneity of cancer stemness and sheds light on optimizing decision-making in immunotherapy and chemotherapy.

FRONTIERS IN IMMUNOLOGY (2022)

添加到收藏夹

Article Immunology

Crosstalk Between Metabolism and Immune Activity Reveals Four Subtypes With Therapeutic Implications in Clear Cell Renal Cell Carcinoma

Yi Wang et al.

Summary: This study identified four immunometabolism subtypes of clear cell renal cell carcinoma, revealing the interplay between immune and metabolic activities and providing new insights into personalized therapy selection.

FRONTIERS IN IMMUNOLOGY (2022)

添加到收藏夹

Review Gastroenterology & Hepatology

Chinese expert consensus on conversion therapy for hepatocellular carcinoma (2021 edition)

Hui-Chuan Sun et al.

Summary: Recent advances in systemic and locoregional treatments have improved response rates for unresectable or advanced HCC patients, allowing some initially unresectable cases to undergo surgical resection through a 'conversion therapy' strategy. Despite promising results, there are still many challenges in the development and implementation of this new approach. Chinese research centers have significant experience in implementing conversion therapy for HCC and have developed consensus statements to guide future clinical practice.

HEPATOBILIARY SURGERY AND NUTRITION (2022)

添加到收藏夹

Article Oncology

The Systematic Analyses of RING Finger Gene Signature for Predicting the Prognosis of Patients with Hepatocellular Carcinoma

Chunfeng Zhang et al.

Summary: This study constructed a prognostic model based on RING finger proteins genes and identified BMI1 as a potential key gene in the prognosis and treatment of HCC.

JOURNAL OF ONCOLOGY (2022)

添加到收藏夹

Article Biochemical Research Methods

Prognosis and personalized treatment prediction in TP53-mutant hepatocellular carcinoma: an in silico strategy towards precision oncology

Chen Yang et al.

Summary: This study retrospectively analyzed 1135 HCC patients and developed a random forest-based prediction model to estimate TP53 mutational status, as well as a robust poor prognosis-associated signature which showed superior ability to predict survival in TP53-mutant patients. In silico screening revealed three targets and two agents that might have potential therapeutic implications in high-PPS patients, presenting a comprehensive view of potential treatment strategy.

BRIEFINGS IN BIOINFORMATICS (2021)

添加到收藏夹

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

添加到收藏夹

Article Cell Biology

TTN/OBSCN 'Double-Hit' predicts favourable prognosis, 'immune-hot' subtype and potentially better immunotherapeutic efficacy in colorectal cancer

Zaoqu Liu et al.

Summary: A recent study revealed that CRC patients with TTN/OBSCN 'Double-Hit' phenotype had significantly better prognosis, an 'immune-hot' subtype, and potentially better immunotherapeutic efficacy.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2021)

添加到收藏夹

Article Genetics & Heredity

Association of RYR2 Mutation With Tumor Mutation Burden, Prognosis, and Antitumor Immunity in Patients With Esophageal Adenocarcinoma

Zaoqu Liu et al.

Summary: The study identified RYR2 gene mutation as a potential biomarker for prognosis, TMB, and immunotherapy of EAC patients, suggesting that patients with RYR2 mutation might benefit more from immunotherapy. Multiple bioinformatics algorithms demonstrated that RYR2 mutation could enhance antitumor immunity and upregulated signaling pathways related to immune response in EAC.

FRONTIERS IN GENETICS (2021)

添加到收藏夹

Article Gastroenterology & Hepatology

Discovery of a Carbamoyl Phosphate Synthetase 1-Deficient HCC Subtype With Therapeutic Potential Through Integrative Genomic and Experimental Analysis

Tong Wu et al.

Summary: This study identified a CPS1-deficient HCC subtype through big-data mining, explored its tumorigenesis mechanism, and found potential therapeutic targets related to metabolic reprogramming in liver cancer.

HEPATOLOGY (2021)

添加到收藏夹

Article Oncology

Afatinib for the Treatment of NSCLC Harboring Uncommon EGFR Mutations: A Database of 693 Cases

James Chih-Hsin Yang et al.

JOURNAL OF THORACIC ONCOLOGY (2020)

添加到收藏夹

Review Gastroenterology & Hepatology

Tumour evolution in hepatocellular carcinoma

Amanda J. Craig et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Integrated pharmaco-proteogenomics defines two subgroups in isocitrate dehydrogenase wild-type glioblastoma with prognostic and therapeutic opportunities

Sejin Oh et al.

NATURE COMMUNICATIONS (2020)

添加到收藏夹

Article Oncology

Afatinib and Temozolomide combination inhibits tumorigenesis by targeting EGFRvIII-cMet signaling in glioblastoma cells

Raghupathy Vengoji et al.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)

添加到收藏夹

Article Oncology

Afatinib, an EGFR inhibitor, decreases EMT and tumorigenesis of Huh-7 cells by regulating the ERK-VEGF/MMP9 signaling pathway

Yafei Chen et al.

MOLECULAR MEDICINE REPORTS (2019)

添加到收藏夹

Article Biochemistry & Molecular Biology

Integrated Proteogenomic Characterization of HBV-Related Hepatocellular Carcinoma

Qiang Gao et al.

CELL (2019)

添加到收藏夹

Article Immunology

The Immune Landscape of Cancer

Vesteinn Thorsson et al.

IMMUNITY (2018)

添加到收藏夹

Article Gastroenterology & Hepatology

A qualitative signature for early diagnosis of hepatocellular carcinoma based on relative expression orderings

Lu Ao et al.

LIVER INTERNATIONAL (2018)

添加到收藏夹

Article Biochemistry & Molecular Biology

Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response

Peng Jiang et al.

NATURE MEDICINE (2018)

添加到收藏夹

Article Biochemistry & Molecular Biology

Differential expression analysis at the individual level reveals a lncRNA prognostic signature for lung adenocarcinoma

Fuduan Peng et al.

MOLECULAR CANCER (2017)

添加到收藏夹

Article Multidisciplinary Sciences

Mutational signatures reveal the dynamic interplay of risk factors and cellular processes during liver tumorigenesis

Eric Letouze et al.

NATURE COMMUNICATIONS (2017)

添加到收藏夹

Article Cell & Tissue Engineering

ERK signaling is required for VEGF-A/VEGFR2-induced differentiation of porcine adipose-derived mesenchymal stem cells into endothelial cells

Sami G. Almalki et al.

STEM CELL RESEARCH & THERAPY (2017)

添加到收藏夹

Article Pharmacology & Pharmacy

Identification of KX2-391 as an inhibitor of HBV transcription by a recombinant HBV-based screening assay

Keisuke Harada et al.

ANTIVIRAL RESEARCH (2017)

添加到收藏夹

Article Biochemistry & Molecular Biology

Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma

Adrian Ally et al.

CELL (2017)

添加到收藏夹

Review Oncology

Tumor microenvironment and cancer therapy resistance

Yu Sun

CANCER LETTERS (2016)

添加到收藏夹

Review Pharmacology & Pharmacy

Afatinib in squamous cell carcinoma of the head and neck

Pol Specenier et al.

EXPERT OPINION ON PHARMACOTHERAPY (2016)

添加到收藏夹

Article Biochemical Research Methods

Robust enumeration of cell subsets from tissue expression profiles

Aaron M. Newman et al.

NATURE METHODS (2015)

添加到收藏夹

Review Genetics & Heredity

Mechanisms underlying mutational signatures in human cancers

Thomas Helleday et al.

NATURE REVIEWS GENETICS (2014)

添加到收藏夹

Article Multidisciplinary Sciences

pRRophetic: An R Package for Prediction of Clinical Chemotherapeutic Response from Tumor Gene Expression Levels

Paul Geeleher et al.

PLOS ONE (2014)

添加到收藏夹

Article Biochemical Research Methods

OncodriveCLUST: exploiting the positional clustering of somatic mutations to identify cancer genes

David Tamborero et al.

BIOINFORMATICS (2013)

添加到收藏夹

Article Biochemical Research Methods

GSVA: gene set variation analysis for microarray and RNA-Seq data

Sonja Haenzelmann et al.

BMC BIOINFORMATICS (2013)

添加到收藏夹

Article Cell Biology

Deciphering Signatures of Mutational Processes Operative in Human Cancer

Ludmil B. Alexandrov et al.

CELL REPORTS (2013)

添加到收藏夹

Article Biotechnology & Applied Microbiology

GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers

Craig H. Mermel et al.

GENOME BIOLOGY (2011)

添加到收藏夹

Article Chemistry, Medicinal

Tyrosine kinase inhibitors.: 17.: Irreversible inhibitors of the epidermal growth factor receptor:: 4-(phenylamino)quinazoline- and 4-(phenylamino)pyrido[3,2-d]pyrimidine-6-acrylamides bearing additional solubilizing functions

JB Smaill et al.

JOURNAL OF MEDICINAL CHEMISTRY (2000)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.